‘Fear and uncertainty’ linger over FDA’s future in wake of Trump admin’s layoffs
During a webinar hosted by NAMSA, experts reflected on what US health agency job cuts could mean for device approvals and innovation.
Pharma industry dodges tariff blow but still braces for disruption
NBE Therapeutics opens ADC research facility in Switzerland
IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility
Uveitis market expected to reach $1.5bn across 7MM by 2033
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
Analysis
View More
Themes
View MoreGoogle-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
EU Health Data Space strikes a chord in EU harmonisation plans
Mastering compliance and copyright in healthcare and MedComms
AstraZeneca director says AI must be a “thought partner” in drug discovery
MeiraGTx and Hologen launch AI-backed gene therapy venture